ArticleQuantitative imaging in medicine and surgery2025
Biparametric magnetic resonance imaging-based radiomics model can improve the detection of dense and sparse prostate cancers.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prostate cancer (PCa) tissues are heterogeneous. The tumor lesion could be either the dense focus consisting of high proportion of malignant glands or the sparse focus consisting of a mixture of scattered tumor glands and normal tissue. The different growth patterns will affect the detection of PCa. The detection rate of the sparse PCa is far lower than that of the dense PCa. This study aimed to explore the value of radiomics based on biparametric magnetic resonance imaging (bpMRI) in the detection of dense and sparse PCa lesions. Methods: A total of 372 PCa lesions of 156 patients from two centers were defined as "sparse" or "dense" according to whole-mount sections and then delineated on bpMR images. For each lesion, 2,553 radiomics features were extracted from images. The optimal radiomics features were selected by one-way analysis of variance (ANOVA) and least absolute shrinkage and selection operator (LASSO) regression. The radiomics models constructed by the random forest classifier and the average apparent diffusion coefficient (ADC) value model were established for the peripheral zone (PZ) and the transitional zone (TZ) to detect dense lesions, sparse lesions, and noncancerous tissues. The areas under the curve (AUCs) and DeLong tests were used to analyze the performance of the models. Results: In the PZ, the AUCs of the radiomics model (external validation set) for noncancerous tissue, dense lesion, and sparse lesion detection were 0.91, 0.98, and 0.88, respectively, and those of the average ADC value model were 0.85, 0.73, and 0.62, respectively. In the TZ, those of the radiomics model were 0.92, 0.93, and 0.88, respectively, and those of the average ADC value model were 0.81, 0.83, and 0.52, respectively. Compared with that of the average ADC value model, the AUC of the radiomics model in the diagnosis of sparse lesions significantly differed (P<0.05). In the detection of dense lesions, there were significant differences in the training set (P<0.05). Conclusions: The radiomics model based on bpMRI can effectively improve the detection of PCa lesions, especially sparse lesions, and significantly reduce missed diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.